Ministry of Food and Drug Safety (MFDS) and US Food and Drug Administration (U.S.

FDA) will jointly host AIRIS2024 (AI Regulatory & International Symposium 2024) from

February 26th (Mon) to 29th (Thu) at Shilla Hotel Seoul under the theme of ‘Use

of AI in Medical Product Development’, as a venue to carry out in-depth discussions

with global regulatory authorities, industry and academia on the developmental

direction and the application of AI technology in the fields of medical products.